Key result
OPCAB yields ~89% actuarial survival at a median follow-up of 2.2 years.
Why the study?
The long-term outcomes of coronary artery bypass without cardiopulmonary bypass (OPCAB) are largely unknown.
What are the long-term clinical outcomes (mortality, stroke, myocardial infarction, target vessel reintervention) after coronary artery bypass without cardiopulmonary bypass (OPCAB)?
Cohort (n=857)
What are the long-term clinical outcomes (mortality, stroke, myocardial infarction, target vessel reintervention) after coronary artery bypass without cardiopulmonary bypass (OPCAB)?
OPCAB is associated with low long-term mortality and clinical event rates, though advanced age and depressed ejection fraction independently predict late mortality.
OPCAB yields favorable mid-term survival in selected patients; leaves open need for randomized trials versus on-pump CABG.
OBJECTIVE: Coronary artery bypass without cardiopulmonary bypass (OPCAB) eliminates the complications related to cardiopulmonary bypass. However, the long-term outcomes of this procedure are largely unknown. METHODS: We sought to investigate the rates of late mortality, stroke, acute myocardial infarction, and target vessel reintervention after OPCAB in a consecutive series of 857 patients who underwent OPCAB between May 1987 and March 1999. RESULTS: Long-term follow-up was obtained for 86% of eligible patients. Actuarial and event-free survival was 89% and 76%, respectively, for a median follow-up period of 2.2 years (range, 0-13.3 years). Risk factors for late mortality were identified with Cox regression analysis. In the multivariate analysis, patient age >75 years (odds ratio, 1.1; 95% confidence interval, 1.0-1.1; P =.01) and an ejection fraction <35% (odds ratio, 2.7; 95% confidence interval, 1.2-6.2; P =.02) emerged as independent predictors of late mortality. CONCLUSION: OPCAB is associated with a low mortality and clinical event rate. Advanced age and depressed ejection fraction may increase mortality after OPCAB.
No takes yet. Share an insight, caveat, or question.
Stamou et al. (2005) conducted a cohort in Coronary artery disease (n=857). Coronary artery bypass without cardiopulmonary bypass (OPCAB) was evaluated on Actuarial survival. Coronary artery bypass without cardiopulmonary bypass (OPCAB) demonstrated 89% actuarial survival and 76% event-free survival at a median follow-up of 2.2 years.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: